Upjohn Inc Human Resources Contracts & Agreements
24 Contracts & Agreements
- Bonus & Incentive Agreements (8 contracts)
- Consulting Agreements (1)
- Employment Agreements (1)
- Retention Agreements (2)
- Separation Agreements (8)
- Severance Agreements (1)
- Transition Agreements (3)
- Separation Agreement and Release with Sanjeev Narula, dated December 15, 2023 (Filed With SEC on February 28, 2024)
- Separation Agreement and Release with Anthony Mauro, dated October 20, 2023 (Filed With SEC on February 28, 2024)
- Retirement and Operating Consulting Agreement and Release with Rajiv Malik, dated October 20, 2023 (Filed With SEC on February 28, 2024)
- Transition and Advisory Agreement and Release, dated May 19, 2023, by and between Viatris Inc. and Robert J. Coury (Filed With SEC on August 7, 2023)
- Form of Performance-Based Restricted Stock Unit Award Agreement under the Viatris Inc. 2020 Stock Incentive Plan for awards granted on or after March 3, 2023 (Filed With SEC on May 8, 2023)
- Separation Agreement with Michael Goettler, dated February 24, 2023 (Filed With SEC on February 27, 2023)
- Form of Director Restricted Stock Unit Award Agreement under the Viatris Inc. 2020 Stock Incentive Plan for non-employee directors for awards granted on or after March 2, 2021 (Filed With SEC on May 10, 2021)
- Form of Performance-Based Restricted Stock Unit Award Agreement under the Viatris Inc. 2020 Stock Incentive Plan for awards granted on or after March 2, 2021 (Filed With SEC on May 10, 2021)
- Form of Restricted Stock Unit Award Agreement under the Viatris Inc. 2020 Stock Incentive Plan for awards granted on or after March 2, 2021 (Filed With SEC on May 10, 2021)
- Executive Employment Agreement, entered into on November 20, 2020, by and between Viatris Inc. and Robert J. Coury (Filed With SEC on March 1, 2021)
- Retention Agreement entered into on December 3, 2020, by and between Viatris Inc. and Anthony Mauro (Filed With SEC on March 1, 2021)
- Retention Agreement entered into on December 3, 2020, by and between Viatris Inc. and Rajiv Malik (Filed With SEC on March 1, 2021)
- Severance Agreement entered into on December 3, 2020 by and between Viatris Inc. and Michael Goettler (Filed With SEC on March 1, 2021)
- Value Creation Incentive Award Performance-Based Restricted Stock Unit Award Agreement for Robert J. Coury under the Viatris Inc. 2020 Stock Incentive Plan, effective as of... (Filed With SEC on March 1, 2021)
- Form of Restricted Stock Unit Award Agreement under the Viatris 2020 Stock Incentive Plan for Michael Goettler and Sanjeev Narula (Filed With SEC on March 1, 2021)
- Form of Retention Restricted Stock Unit Award Agreement under the Viatris 2020 Stock Incentive Plan (Filed With SEC on March 1, 2021)
- Form of Make-Whole Restricted Stock Unit Award Agreement under the Viatris 2020 Stock Incentive Plan (Filed With SEC on March 1, 2021)
- Transition Services Agreement, dated as of November 16, 2020, by and between Upjohn Inc. (as Service Provider) and Pfizer Inc. (as Service Recipient) (Filed With SEC on November 19, 2020)
- Transition Services Agreement, dated as of November 16, 2020, by and between Pfizer Inc. (as Service Provider) and Upjohn Inc. (as Service Recipient) (Filed With SEC on November 19, 2020)
- Amendment No. 4 to the Separation and Distribution Agreement, dated as of November 15, 2020, by and between Pfizer Inc. and Upjohn Inc (Filed With SEC on November 19, 2020)
- Amendment No. 3 to the Separation and Distribution Agreement, dated as of September 18, 2020, by and between Pfizer Inc. and Upjohn Inc (Filed With SEC on November 19, 2020)
- Amendment No. 3, dated as of September 18, 2020, to the Separation and Distribution Agreement, dated as of July 29, 2019, by and between Pfizer Inc. and Upjohn Inc (Filed With SEC on November 10, 2020)
- Amendment No. 2, dated as of May 29, 2020, to the Separation and Distribution Agreement, dated as of July 29, 2019, by and between Pfizer Inc. and Upjohn Inc (Filed With SEC on June 2, 2020)
- Amendment No. 1 to the Separation and Distribution Agreement, dated as of February 18, 2020, by and between Pfizer Inc. and Upjohn Inc (Filed With SEC on May 12, 2020)
